Couples-focused HIV prevention program
A couples-based HIV biobehavioral prevention intervention
['FUNDING_R01'] · UNIVERSITY OF CENTRAL FLORIDA · NIH-11251327
A brief three-session program for adult couples to learn about HIV prevention options like PrEP and treatment and get support to use them consistently.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CENTRAL FLORIDA (nih funded) |
| Locations | 1 site (ORLANDO, UNITED STATES) |
| Trial ID | NIH-11251327 on ClinicalTrials.gov |
What this research studies
If you and your partner join, you'll take part in three sessions that mix clear medical information about PrEP and HIV treatment with practical relationship and communication skills. Much of the program can be done remotely, and the study team will use objective biomarkers (for example, blood or swab tests) to track how well prevention medications are being used. The trial includes couples regardless of whether one, both, or neither partner has HIV and builds on a small pilot that found the approach acceptable. The study aims to strengthen prevention steps couples can take together and measure whether those changes lead to better protection from HIV.
Who could benefit from this research
Good fit: Adult couples (generally 21 or older) in a relationship where one or both partners may be at risk for HIV or one partner is living with HIV, who are willing to participate together and provide home or clinic samples.
Not a fit: Single people, couples unwilling to participate together or provide biological samples, or those already consistently protected and adherent to prevention/treatment may not receive direct benefit.
Why it matters
Potential benefit: If successful, the program could help couples improve protection against HIV by increasing knowledge, medication adherence, and relationship support for prevention.
How similar studies have performed: Small pilot trials of this couples approach showed feasibility and promising signals, but larger trials are still needed to confirm real-world effectiveness.
Where this research is happening
ORLANDO, UNITED STATES
- UNIVERSITY OF CENTRAL FLORIDA — ORLANDO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MARTINEZ, OMAR — UNIVERSITY OF CENTRAL FLORIDA
- Study coordinator: MARTINEZ, OMAR
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus